M Cell DNA Vaccination for CTL Immunity to HIV (Q51647988)

8 April 2018

title

M Cell DNA Vaccination for CTL Immunity to HIV (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

23 March 2024

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

23 March 2024

4

Mohamed T. Shata

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568947

23 March 2024

author name string

Xinhai Wang

1

1 reference

8 April 2018

Asmahan Haddad

3

1 reference

8 April 2018

David M. Hone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568947

23 March 2024

David W. Pascual

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14568947

23 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

8 April 2018

full work available at URL

published in

Journal of Immunology

1 reference

8 April 2018

volume

171

1 reference

8 April 2018

issue

9

1 reference

8 April 2018

page(s)

4717-4725

1 reference

8 April 2018

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

cites work

2

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

23 March 2024

3

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

23 March 2024

4

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization

23 March 2024

5

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.

23 March 2024

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees

23 March 2024

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter

23 March 2024

8

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria

23 March 2024

10

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles

23 March 2024

12

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Biodegradable microspheres as a vaccine delivery system

23 March 2024

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells

23 March 2024

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Transferrin-polycation conjugates as carriers for DNA uptake into cells

23 March 2024

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes

23 March 2024

18

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes

23 March 2024

19

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Receptor-mediated transfection of murine and ovine mammary glands in vivo

23 March 2024

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Protein sigma 1 is the reovirus cell attachment protein

23 March 2024

22

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

The N-terminal quarter of reovirus cell attachment protein sigma 1 possesses intrinsic virion-anchoring function

23 March 2024

23

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Biochemical and biophysical characterization of the reovirus cell attachment protein sigma 1: evidence that it is a homotrimer

23 March 2024

24

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Evidence that the sigma 1 protein of reovirus serotype 3 is a multimer.

23 March 2024

25

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Gene transfer facilitated by a cellular targeting molecule, reovirus protein sigma1.

23 March 2024

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

M cell-targeted DNA vaccination

23 March 2024

27

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

23 March 2024

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Gamma interferon is not essential in host defense against disseminated candidiasis in mice

23 March 2024

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector

23 March 2024

30

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes

23 March 2024

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Development of a transient CD4(+)CD8(+) T cell subset in the cervical lymph nodes following intratracheal instillation with an adenovirus vector.

23 March 2024

34

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

23 March 2024

35

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity

23 March 2024

36

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.

23 March 2024

37

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells

23 March 2024

38

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

M cells and the pathogenesis of mucosal and systemic infections

23 March 2024

39

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration

23 March 2024

40

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins

23 March 2024

42

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes

23 March 2024

43

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

23 March 2024

45

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

23 March 2024

46

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

23 March 2024

47

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.

23 March 2024

48

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

23 March 2024

50

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Low levels of perforin expression in CD8+ T lymphocyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection

23 March 2024

51

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic

23 March 2024

52

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection

23 March 2024

53

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.9.4717

23 March 2024

Identifiers

1 reference

8 April 2018

1 reference

8 April 2018